Molecules, 2019 A rapid and sensitive method was established for arsenic (As) speciation based on high performance liquid chromatography coupled to inductively coupled plasma mass spectrometry (HPLC-ICP-MS).
Qiaoli Shi +7 more
doaj +1 more source
Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State [PDF]
, 2016 The mitochondrial thioredoxin system (NADPH, thioredoxin reductase, thioredoxin) is a major redox regulator. Here we have investigated the redox correlation between this system and the mitochondrial enzyme cyclophilin D.
Bindoli, Alberto +7 more
core +1 more source
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): a Gene Expression Study [PDF]
, 2018 L
Canesastraro, Martina +7 more
core +1 more source
Management of elderly patients with acute promyelocytic leukemia: progress and problems [PDF]
, 2013 Despite substantial progress in the management and outcome of acute promyelocytic leukemia (APL) during the last decades, older age remains a prominent negative prognostic factor.
Eva Lengfelder +2 more
core +1 more source
Protective Effect of α-Lipoic Acid Against Arsenic Trioxide–Induced Acute Cardiac Toxicity in Rats
Journal of Pharmacological Sciences, 2011 The clinical use of arsenic trioxide (ATO) is often limited because of its adverse effects. We examined whether α-lipoic acid (LA) protects against the ATO-induced cardiac toxicity.
Masafumi Kumazaki +7 more
doaj +1 more source
Sound mining in the North : a guide to environmental regulation and best practices supporting social sustainability [PDF]
, 2014 Julkaistu ...
Hast, Sanna +11 more
core
Morphine Attenuated the Cytotoxicity Induced by Arsenic Trioxide in H9c2 Cardiomyocytes. [PDF]
, 2016 Arsenic trioxide (ATO) is an efficient drug for the treatment of the patients with acute promyelocytic leukemia (APL). Inhibition of proliferation as well as apoptosis, attenuation of migration, and induction of differentiation in tumor cells are the ...
Amini-Khoei, Hossein. +10 more
core
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study [PDF]
, 2011 John S. Welch +11 more
openalex +1 more source
Arsenic Trioxide in Patients with Refractory Multiple Myeloma: A Prospective, Phase II, Single-Arm Study [PDF]
Acta Medica Iranica, 2011 Multiple myeloma (MM) characterized by proliferation of plasma cells in bone marrow and production of monoclonal immunoglobulin's. Recently, arsenic trioxide (ATO), has been considered for treatment refractory MM.
Zohreh Sanaat +4 more
doaj +1 more source